Trials / Completed
CompletedNCT00928590
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 155 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the long-term safety of a fixed combination product containing an alternative preservative, dosed once daily for 12 months, in patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost/Timolol Maleate Fixed Combination solution |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-06-26
- Last updated
- 2014-07-18
Source: ClinicalTrials.gov record NCT00928590. Inclusion in this directory is not an endorsement.